We observed enriched phospho-STAT6 staining in DLBCL patient biopsies with a STAT6D419 mutation [9], suggesting that these mutations lead to a constitutively active STAT6, altered kinetics of response to cytokine, or increased cytokine signaling from the microenvironment. Here, STAT6 is linked to diffuse large B-cell lymphoma.